Počet záznamov: 1

certolizumab pegol

SYS		d000068582
LBL		00000nx^^^2200181-^^45^^
005		20240119201227.0
100		$a 20160101csloy0103 ba0
152		$b mesh
250		$a certolizumab pegol $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x TO $x TU $x UL $x UR $8 slo
300	1-	$a 2016 (2003) $8 eng
330	1-	$a A polyethylene-glycolated Fab' fragment of TUMOR NECROSIS FACTOR antibody that binds specifically to TNF-ALPHA and neutralises it in a dose-dependent manner. It also inhibits the production of lipopolysaccharide-induced TNF-ALPHA and IL-1 BETA and is used to treat RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS. $8 eng
450		$a CDP870 $5 e $8 slo
550		$3 sllk_un_auth*d014409 $Y Tumor Necrosis Factor-alpha $5 F $a faktor nekrotizujúci nádory, alfa
550		$3 sllk_un_auth*d014409 $Y Tumor Necrosis Factor-alpha $5 B $a faktor nekrotizujúci nádory, alfa
686		$a D05.750.741.125
686		$a D12.644.541.500.650.250
686		$a D12.776.124.486.485.114.224.060.500
686		$a D12.776.124.486.485.680.650.250
686		$a D12.776.124.790.651.114.224.060.500
686		$a D12.776.124.790.651.680.650.250
686		$a D12.776.377.715.548.114.224.200.500
686		$a D12.776.377.715.548.680.650.250
750		$a Certolizumab Pegol $8 eng
801	-0	$a SK $b BA006 $c 20160207
801	-2	$a SK $b BA006 $c 20160209
980		$x M

Počet záznamov: 1